XTX Topco’s AIM ImmunoTech AIM Stock Holding History

XTX Topco’s Portfolio AIM Stock Details AIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$12K	Buy	+20,590	New	+$20.9K	﹤0.01%	3648
2025 Q2	–	Sell	-836	Closed	-$10.2K	–	3412
2025 Q1	$10.2K	Buy	836 +343	+70%	+$5.51K	﹤0.01%	2247
2024 Q4	$9.74K	Sell	493 -167	-25%	-$3.89K	﹤0.01%	2152
2024 Q3	$17.8K	Buy	660 +515	+355%	+$17.2K	﹤0.01%	1863
2024 Q2	$5.41K	Buy	145 +4	+3%	+$170	﹤0.01%	1742
2024 Q1	$6.65K	Buy	+141	New	+$5.84K	﹤0.01%	1697
2021 Q3	–	Sell	-293	Closed	-$63K	–	1229
2021 Q2	$63K	Buy	+293	New	+$62.8K	0.02%	712

Other funds holding AIM

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Community Bank Dewitt, New York $840M AUM 22.23% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

XTX Topco's AIM Position: Q1 2026 in Review

XTX Topco opened a new position in AIM ImmunoTech (AIM) in Q1 2026: 20,590 shares worth $12K. The stake represents ﹤0.01% of the portfolio and ranks #3648 among its holdings. This is a return to the name: XTX Topco previously reported a position in AIM as recently as Q1 2025.

XTX Topco first reported a position in AIM in Q2 2021 and has held it in 7 quarters since. The position peaked at $63K in Q2 2021. 18 funds tracked by Wall St. Rank hold AIM as of Q1 2026.

XTX Topco held 20,590 shares of AIM ImmunoTech worth $12K as of Q1 2026.
AIM ImmunoTech was a new XTX Topco position in Q1 2026.
AIM ImmunoTech made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3648 holding.
XTX Topco first reported a position in AIM ImmunoTech in Q2 2021 and has held it in 7 quarters since.
XTX Topco's AIM ImmunoTech position peaked at $63K in Q2 2021.
18 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.